See also this year's filing and all EDGAR filings for this company.
PDF Report 0001080709_2018_ARENA_PHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('stock_price')"} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 25, '100040 - Statement - Consolidated Statements of Operations and Comprehensive Loss2': 2}} |
Graph
Absolute values for 0001080709, ARENA PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 281,280,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 30,131,000 |
| 3 | remainder_Assets | 27,864,000 |
| 4 | LiabilitiesCurrent | 72,327,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 30,341,000 |
| 9 | ResearchAndDevelopmentExpense | 70,988,000 |
| 10 | remainder_Expenses | 11,975,000 |
| 11 | remainder_Revenues | 21,337,000 |
| 12 | remainder_NetIncome | -765,000 |
| 13 | remainder_ComprehensiveNetIncome | 3,208,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 339,275,000 |
| 1 | Liabilities | 72,327,000 |
| 2 | Expenses | 113,304,000 |
| 3 | Revenues | 21,337,000 |
| 4 | StockholdersEquity | 266,948,000 |
| 5 | NetIncome | -92,732,000 |
| 6 | ComprehensiveNetIncome | -91,128,000 |
| 7 | BaseVar | 275,108,000 |
| 8 | EconomicCapitalRatio | 1.79 |
Edgar->Model Mapping
Feature Distribution
Change over Time
